Healthcare - Biotechnology - NASDAQ - US
$ 0.5655
-9.14 %
$ 21.6 M
Market Cap
-0.32
P/E
Price Target
Average
76.83%
Revenue Forecast
Estimate
33.48%
EBIT
Estimate
24.32%
Net Income
Estimate
40.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bolt Biotherapeutics, Inc.
Wall Street analysts predict an average 1-year price target for BOLT of $1 , with forecasts ranging from a low of $1 to a high of $1 .
BOLT Lowest Price Target
Wall Street Target
1 USD
76.83%
BOLT Average Price Target
Wall Street Target
1 USD
76.83%
BOLT Highest Price Target
Wall Street Target
1 USD
76.83%
REVENUE FORECAST
Revenue Forecast Chart BOLT
EBIT FORECAST
EBIT Forecast Chart BOLT
NET INCOME FORECAST
Net Income Chart BOLT